WuXi AppTec's 25th original liquid production plant has completed the first batch of GMP production.

On June 24th, WuXi Biologics announced that its Biological Drug Substance Plant MFG17 located in Fengxian, Shanghai has successfully completed the first batch of GMP production. According to WuXi Biologics, MFG17 is equipped with multiple sets of disposable bioreactors, with a production capacity of 9000 liters and the ability to produce 80-100 batches of drug substance annually.